PetMeds® Announces Participation in Sidoti & Company's Small-Cap Virtual Investor Conference

CEO and President Matt Hulett, along with CFO Christine Chambers, will address institutional investors and other attendees at the upcoming event that runs Sept. 21-22.

DELRAY BEACH, Fla., Sept. 12, 2022 /PRNewswire-PRWeb/ -- PetMed Express, Inc. PETS, Your Trusted Pet Health Expert®, will attend Sidoti & Company's Small-Cap Virtual Investor Conference, set for Sept. 21-22.

PetMed Express CEO and President Matt Hulett and CFO Christine Chambers will represent the company in the virtual event, accessible only to Sidoti clients, for one-on-one meetings with attendees.

PetMeds® will join dozens of other leading small-cap companies at Sidoti's September conference, expected to draw up to 500 North American institutional investment firms. Sidoti is an independent equity research firm and registered broker dealer that has over two decades of experience in the small- and micro-cap arena. For more information on the conference, click here: https://www.sidoti.com/events/fall-small-cap-virtual-conference.

###

ABOUT PETMEDS®
Founded in 1996, Petmeds.com is Your Trusted Pet Health Expert, providing fast, easy and helpful service to over 10 million customers across North America. PetMeds delivers prescription and non-prescription medications and pet supplies for less, direct to the consumer through its PetMeds® toll-free number, on the Internet through its website Petmeds.com, or with the PetMeds® free mobile app available for Apple and Android devices.

FORWARD LOOKING STATEMENTS: The statements contained in this press release that are not purely historical are forward-looking statements, including statements regarding PetMeds' expectations, beliefs, intentions or strategies regarding the future. All forward-looking statements included in this press release are based upon information available to PetMeds as of the date hereof, and PetMeds assumes no obligation to update any such forward-looking statements. Forward-looking statements involve risks and uncertainties, which could cause actual results to differ materially from those projected. These and other risks relating to PetMeds' business are set forth in PetMeds' Form 10-K for the fiscal year ended March 31, 2022, filed with the Securities and Exchange Commission.

INVESTOR RELATIONS CONTACT
investor@1800petmeds.com

MEDIA CONTACT
Mary Eva Tredway
Butin PR
maryeva@butinpr.com

Media Contact

Leah Walker, PetMeds, 5615264444, press@1800petmeds.com

Twitter

SOURCE PetMeds